Zolbetuximab-based chemotherapy in CLDN18.2-positive gastric cancer: real-world tumor response and early albumin kinetics
2026 · Japanese Journal of Clinical Oncology · 0 citations
https://doi.org/10.1093/jjco/hyag024
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
0
Papers
0
Citations
Kazuyoshi Yamamoto is an academic researcher.
Click to start Chat